Dataset Information


LINC00261 Is Differentially Expressed in Pancreatic Cancer Subtypes and Regulates a Pro-Epithelial Cell Identity.

ABSTRACT: Pancreatic adenocarcinoma (PDAC) is one of the major causes of cancer-associated deaths worldwide, with a dismal prognosis that has not significantly changed over the last decades. Transcriptional analysis has provided valuable insights into pancreatic tumorigenesis. Specifically, pancreatic cancer subtypes were identified, characterized by specific mutations and gene expression changes associated with differences in patient survival. In addition to differentially regulated mRNAs, non-coding RNAs, including long non-coding RNAs (lncRNAs), were shown to have subtype-specific expression patterns. Hence, we aimed to characterize prognostic lncRNAs with deregulated expression in the squamous subtype of PDAC, which has the worst prognosis. Extensive in silico analyses followed by in vitro experiments identified long intergenic non-coding RNA 261 (LINC00261) as a downregulated lncRNA in the squamous subtype of PDAC, which is generally associated with transforming growth factor ? (TGF?) signaling in human cancer cells. Its genomic neighbor, the transcription factor forkhead box protein A2 (FOXA2), regulated LINC00261 expression by direct binding of the LINC00261 promoter. CRISPR-mediated knockdown and promoter knockout validated the importance of LINC00261 in TGF?-mediated epithelial-mesenchymal transition (EMT) and established the epithelial marker E-cadherin, an important cell adhesion protein, as a downstream target of LINC00261. Consequently, depletion of LINC00261 enhanced motility and invasiveness of PANC-1 cells in vitro. Altogether, our data suggest that LINC00261 is an important tumor-suppressive lncRNA in PDAC that is involved in maintaining a pro-epithelial state associated with favorable disease outcome.


PROVIDER: S-EPMC7281485 | BioStudies | 2020-01-01

SECONDARY ACCESSION(S): 10.18632/oncotarget.10891

REPOSITORIES: biostudies

altmetric image


Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.

Zhou Meng M   Diao Zhiyong Z   Yue Xiaolong X   Chen Yang Y   Zhao Hengqiang H   Cheng Liang L   Sun Jie J  

Oncotarget 20160801 35

It is increasing evidence that ceRNA activity of long non-coding RNAs (lncRNAs) played critical roles in both normal physiology and tumorigenesis. However, functional roles and regulatory mechanisms of lncRNAs as ceRNAs in pancreatic ductal adenocarcinoma (PDAC), and their potential implications for early diagnosis remain unclear. In this study, we performed a genome-wide analysis to investigate potential lncRNA-mediated ceRNA interplay based on "ceRNA hypothesis". A dysregulated lncRNA-associat  ...[more]

Similar Datasets

2017-01-01 | S-EPMC5387161 | BioStudies
2018-01-01 | S-EPMC6468413 | BioStudies
2019-01-01 | S-EPMC6571057 | BioStudies
2020-01-01 | S-EPMC7423336 | BioStudies
2016-01-01 | S-EPMC4955208 | BioStudies
2019-03-01 | GSE110182 | GEO
2021-01-01 | S-EPMC7840721 | BioStudies
1000-01-01 | S-EPMC6148000 | BioStudies
2020-01-01 | S-EPMC7482811 | BioStudies
2018-01-01 | S-EPMC5947154 | BioStudies